Evidence map›Paper›PMID 25750072›Full record

Trial reportJournal of neurovirology2015

The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.

Manisha Ghate, Sanjay Mehendale, Rachel Meyer, Anya Umlauf, Reena Deutsch, Rujvi Kamat, Madhuri Thakar, Arun Risbud, Smita Kulkarni, Maiko Sakamoto and 6 more

Abstract readClinical Trial
In one paragraph

Trial report in Journal of neurovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  5. Article
  6. Neurocognitive Complications of HIV Infection in Low-Income Countries.Current topics in behavioral neurosciences · 2021
    Article
  7. Article
  8. Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. HIV-Associated Neurocognitive Disorders: A Global Perspective.Journal of the International Neuropsychological Society : JINS · 2017
    Review
  13. Neuropsychological Assessment: Past and Future.Journal of the International Neuropsychological Society : JINS · 2017
    Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Manisha GhateNational AIDS Research Institute, Post Box 1895, G-73, MIDC, Bhosari, Pune, Maharashtra, 411026, India, mghate@nariindia.org.
Sanjay Mehendale
Rachel Meyer
Anya Umlauf
Reena Deutsch
Rujvi Kamat
Madhuri Thakar
Arun Risbud
Smita Kulkarni
Maiko Sakamoto
Terry Alexander
Donald Franklin
Scott Letendre
Robert K Heaton
Igor Grant
Thomas D Marcotte

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
Interdisciplinary Research Fellowship in NeuroAIDSR25MH081482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARIANA CHERNER · 2007 to 2026
$5.2M
NeuroAIDS in IndiaR01MH078748 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARCOTTE, THOMAS D · 2007 to 2011
$2.9M
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance AbuseK24DA040550 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2015 to 2025
$1.8M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
NIDA NIH HHS K24 DA040550NIMH NIH HHS K24 MH097673NIMH NIH HHS P30 MH062512NIMH NIH HHS P30 MH62512NIMH NIH HHS R01 MH078748NIMH NIH HHS R01 MH78748NIMH NIH HHS R25 MH081482
6 · The paper itself

Abstract

There has been a reduction in the most severe cases of HIV-associated neurocognitive disorders (HAND) with advances in antiretroviral treatment (ART). But the prevalence of milder forms of HAND still remains high. Data from systematically conducted studies on the effects of ART on cognition are scanty in India, where HIV-1 clade C is prevalent. The purpose of the present study was to assess the effect of antiretroviral therapy in HIV-seropositive (HIV+) individuals (n = 92) with CD4 cell counts <200 cells/mm(3). The overall and domain-specific levels of cognitive functioning were determined using a locally recruited normative sample, and a change in neurocognitive functioning at the 1-year follow-up visit was analyzed. Results revealed cognitive impairment in 44.6 % of the HIV+ group at baseline. At the 1-year follow-up, the group showed significant improvement in the Learning domain (p < 0.05). HIV+ individuals showing improvement in the global cognitive scores had a significantly lower baseline CD4 cell count compared to others. Overall, the degree of improvement associated with the magnitude of rise in CD4 suggests the possibility that early, mild subclinical deficits may also benefit from treatment.

Indexed as

AdultAIDS Dementia ComplexAnti-Retroviral AgentsCD4 Lymphocyte CountFemaleHIV-1HumansIndiaMaleNeuropsychological TestsAnti-Retroviral Agents

Identifiers

PMID25750072
PMCPMC4512904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.